CVE-2024-50405
QTS, QuTS hero
An improper neutralization of CRLF sequences ('CRLF Injection') vulnerability has been reported to affect several QNAP operating system versions. If exploited, the vulnerability could allow remote attackers who have gained administrator access to modify application data.
We have already fixed the vulnerability in the following versions: QTS 5.2.3.3006 build 20250108 and later QuTS hero h5.2.3.3006 build 20250108 and later
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- High
- User interaction
- None
What an attacker can affect
- Confidentiality
- None
- Integrity
- Low
- Availability
- None
Exploit likelihood
What each source reports
CVE List Score used
QTS, QuTS hero
An improper neutralization of CRLF sequences ('CRLF Injection') vulnerability has been reported to affect several QNAP operating system versions. If exploited, the vulnerability could allow remote attackers who have gained administrator access to modify application data.
We have already fixed the vulnerability in the following versions: QTS 5.2.3.3006 build 20250108 and later QuTS hero h5.2.3.3006 build 20250108 and later
- Record
CVE-2024-50405- CVSS 4.0
- 5.1 Medium
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N - CVSS 3.1
- 5.5 Medium
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:N/I:L/A:L - Weakness
- CWE-93, CWE-94, CWE-94
- Updated
- 2026-11-02
EUVDEUVD-2024-54223
An improper neutralization of CRLF sequences ('CRLF Injection') vulnerability has been reported to affect several QNAP operating system versions. If exploited, the vulnerability could allow remote attackers who have gained administrator access to modify application data.
We have already fixed the vulnerability in the following versions: QTS 5.2.3.3006 build 20250108 and later QuTS hero h5.2.3.3006 build 20250108 and later
- Record
EUVD-2024-54223- CVSS 4.0
- 5.1 Medium
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-744j-f9r9-w6h7
An improper neutralization of CRLF sequences ('CRLF Injection') vulnerability has been reported...
An improper neutralization of CRLF sequences ('CRLF Injection') vulnerability has been reported to affect several QNAP operating system versions. If exploited, the vulnerability could allow remote attackers who have gained administrator access to modify application data.
We have already fixed the vulnerability in the following versions: QTS 5.2.3.3006 build 20250108 and later QuTS hero h5.2.3.3006 build 20250108 and later
- Record
GHSA-744j-f9r9-w6h7- CVSS 4.0
- 5.1 Medium
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - CVSS 3.1
- 5.5 Medium
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:N/I:L/A:L - Weakness
- CWE-93, CWE-94
- Updated
- 2026-11-02
NVD
An improper neutralization of CRLF sequences ('CRLF Injection') vulnerability has been reported to affect several QNAP operating system versions. If exploited, the vulnerability could allow remote attackers who have gained administrator access to modify application data.
We have already fixed the vulnerability in the following versions: QTS 5.2.3.3006 build 20250108 and later QuTS hero h5.2.3.3006 build 20250108 and later
- Record
CVE-2024-50405- CVSS 4.0
- 5.1 Medium
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X - CVSS 3.1
- 5.5 Medium
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:N/I:L/A:L - Weakness
- CWE-93, CWE-94
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2024-50405 is a medium vulnerability (CVSS 5.1) in Qnap Qts, published March 7, 2025. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.41%, the 35th percentile. No source names a fixed version.